Infusystem Holdings Inc (INFU)

$7.52

+0.1

(+1.35%)▲

Market is closed - opens 7 PM, 06 May 2024

Insights on Infusystem Holdings Inc

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 31.90M → 31.77M (in $), with an average decrease of 0.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 689.0K → 72.0K (in $), with an average decrease of 44.8% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 25.1% return, outperforming this stock by 42.0%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 36.5% return, outperforming this stock by 101.2%

Performance

  • $7.40
    $7.66
    $7.52
    downward going graph

    1.6%

    Downside

    Day's Volatility :3.39%

    Upside

    1.83%

    downward going graph
  • $7.42
    $11.44
    $7.52
    downward going graph

    1.33%

    Downside

    52 Weeks Volatility :35.14%

    Upside

    34.27%

    downward going graph

Returns

PeriodInfusystem Holdings IncSector (Health Care)Index (Russel 2000)
3 Months
-18.7%
-1.1%
0.0%
6 Months
-20.59%
10.5%
0.0%
1 Year
-16.91%
5.4%
0.5%
3 Years
-64.69%
14.4%
-21.1%

Highlights

Market Capitalization
172.7M
Book Value
$2.47
Earnings Per Share (EPS)
0.04
PE Ratio
203.0
PEG Ratio
0.0
Wall Street Target Price
14.83
Profit Margin
0.69%
Operating Margin TTM
3.95%
Return On Assets TTM
2.53%
Return On Equity TTM
1.74%
Revenue TTM
125.8M
Revenue Per Share TTM
5.98
Quarterly Revenue Growth YOY
10.100000000000001%
Gross Profit TTM
62.5M
EBITDA
16.5M
Diluted Eps TTM
0.04
Quarterly Earnings Growth YOY
-0.99
EPS Estimate Current Year
0.17
EPS Estimate Next Year
0.4
EPS Estimate Current Quarter
0.02
EPS Estimate Next Quarter
0.04

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Infusystem Holdings Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 97.21%

Current $7.52
Target $14.83

Company Financials

FY18Y/Y Change
Revenue
67.1M
↓ 5.54%
Net Income
-1.1M
↓ 94.71%
Net Profit Margin
-1.63%
↑ 27.5%
FY19Y/Y Change
Revenue
81.1M
↑ 20.82%
Net Income
1.4M
↓ 224.29%
Net Profit Margin
1.68%
↑ 3.31%
FY20Y/Y Change
Revenue
97.4M
↑ 20.06%
Net Income
17.3M
↑ 1173.48%
Net Profit Margin
17.8%
↑ 16.12%
FY21Y/Y Change
Revenue
102.4M
↑ 5.13%
Net Income
1.4M
↓ 91.81%
Net Profit Margin
1.39%
↓ 16.41%
FY22Y/Y Change
Revenue
109.9M
↑ 7.36%
Net Income
18.0K
↓ 98.73%
Net Profit Margin
0.02%
↓ 1.37%
FY23Y/Y Change
Revenue
125.8M
↑ 14.44%
Net Income
872.0K
↑ 4744.44%
Net Profit Margin
0.69%
↑ 0.67%
Q4 FY22Q/Q Change
Revenue
28.8M
↑ 5.69%
Net Income
107.0K
↓ 75.85%
Net Profit Margin
0.37%
↓ 1.25%
Q1 FY23Q/Q Change
Revenue
30.4M
↑ 5.34%
Net Income
-324.0K
↓ 402.8%
Net Profit Margin
-1.07%
↓ 1.44%
Q2 FY23Q/Q Change
Revenue
31.7M
↑ 4.49%
Net Income
435.0K
↓ 234.26%
Net Profit Margin
1.37%
↑ 2.44%
Q3 FY23Q/Q Change
Revenue
31.9M
↑ 0.55%
Net Income
689.0K
↑ 58.39%
Net Profit Margin
2.16%
↑ 0.79%
Q4 FY23Q/Q Change
Revenue
31.8M
↓ 0.43%
Net Income
72.0K
↓ 89.55%
Net Profit Margin
0.23%
↓ 1.93%
Q1 FY24Q/Q Change
Revenue
31.8M
↑ 0.0%
Net Income
72.0K
↑ 0.0%
Net Profit Margin
0.23%
↑ 0.0%
FY18Y/Y Change
Total Assets
64.1M
↓ 6.98%
Total Liabilities
43.6M
↑ 15.04%
FY19Y/Y Change
Total Assets
79.2M
↑ 23.65%
Total Liabilities
56.9M
↑ 30.39%
FY20Y/Y Change
Total Assets
97.0M
↑ 22.43%
Total Liabilities
56.2M
↓ 1.14%
FY21Y/Y Change
Total Assets
97.6M
↑ 0.61%
Total Liabilities
49.3M
↓ 12.31%
FY22Y/Y Change
Total Assets
99.4M
↑ 1.85%
Total Liabilities
51.4M
↑ 4.2%
FY23Y/Y Change
Total Assets
109.9M
↑ 10.56%
Total Liabilities
57.6M
↑ 12.06%
Q4 FY22Q/Q Change
Total Assets
99.4M
↑ 0.41%
Total Liabilities
51.4M
↑ 0.41%
Q1 FY23Q/Q Change
Total Assets
102.3M
↑ 2.89%
Total Liabilities
54.0M
↑ 5.09%
Q2 FY23Q/Q Change
Total Assets
102.7M
↑ 0.48%
Total Liabilities
52.8M
↓ 2.24%
Q3 FY23Q/Q Change
Total Assets
102.1M
↓ 0.66%
Total Liabilities
50.6M
↓ 4.15%
Q4 FY23Q/Q Change
Total Assets
102.9M
↑ 0.83%
Total Liabilities
50.6M
↑ 0.02%
Q1 FY24Q/Q Change
Total Assets
109.9M
↑ 6.77%
Total Liabilities
57.6M
↑ 13.77%
FY18Y/Y Change
Operating Cash Flow
11.4M
↑ 50.22%
Investing Cash Flow
-5.0M
↓ 573.31%
Financing Cash Flow
-5.6M
↓ 35.11%
FY19Y/Y Change
Operating Cash Flow
13.9M
↑ 21.81%
Investing Cash Flow
-19.6M
↑ 294.12%
Financing Cash Flow
4.1M
↓ 173.71%
FY20Y/Y Change
Operating Cash Flow
20.3M
↑ 46.16%
Investing Cash Flow
-12.2M
↓ 38.08%
Financing Cash Flow
-1.1M
↓ 127.26%
FY21Y/Y Change
Operating Cash Flow
18.3M
↓ 9.68%
Investing Cash Flow
-21.3M
↑ 75.26%
Financing Cash Flow
-6.5M
↑ 478.6%
FY22Y/Y Change
Operating Cash Flow
17.5M
↓ 4.36%
Investing Cash Flow
-11.5M
↓ 46.15%
Financing Cash Flow
-6.1M
↓ 6.24%
Q4 FY22Q/Q Change
Operating Cash Flow
4.6M
↑ 32.12%
Investing Cash Flow
-3.1M
↓ 12.85%
Financing Cash Flow
-1.7M
↓ 1846.94%
Q1 FY23Q/Q Change
Operating Cash Flow
-151.0K
↓ 103.31%
Investing Cash Flow
-3.1M
↓ 0.03%
Financing Cash Flow
3.3M
↓ 292.35%
Q2 FY23Q/Q Change
Operating Cash Flow
2.5M
↓ 1723.84%
Investing Cash Flow
-2.3M
↓ 23.34%
Financing Cash Flow
-235.0K
↓ 107.14%

Technicals Summary

Sell

Neutral

Buy

Infusystem Holdings Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Infusystem Holdings Inc
Infusystem Holdings Inc
-9.51%
-20.59%
-16.91%
-64.69%
74.88%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-1.81%
37.55%
25.09%
36.46%
125.0%
Resmed Inc.
Resmed Inc.
14.95%
41.01%
-6.33%
12.66%
92.65%
Becton, Dickinson And Company
Becton, Dickinson And Company
-4.67%
-9.42%
-7.48%
-6.04%
-1.61%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-7.36%
9.61%
-0.93%
11.08%
197.3%
Alcon Ag
Alcon Ag
-6.17%
7.59%
7.98%
13.61%
33.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Infusystem Holdings Inc
Infusystem Holdings Inc
203.0
203.0
0.0
0.17
0.02
0.03
NA
2.47
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
67.57
67.57
7.13
6.28
0.16
0.08
NA
39.37
Resmed Inc.
Resmed Inc.
30.38
30.38
1.75
7.4
0.22
0.11
0.01
30.47
Becton, Dickinson And Company
Becton, Dickinson And Company
53.75
53.75
1.34
12.95
0.05
0.03
0.02
87.68
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
49.01
49.01
6.72
7.62
0.21
0.12
0.0
39.2
Alcon Ag
Alcon Ag
40.22
40.22
4.59
3.06
0.05
0.02
0.0
41.81
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Infusystem Holdings Inc
Infusystem Holdings Inc
Buy
$172.7M
74.88%
203.0
0.69%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$133.0B
125.0%
67.57
27.16%
Resmed Inc.
Resmed Inc.
Buy
$27.0B
92.65%
30.38
19.77%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.6B
-1.61%
53.75
6.44%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$28.2B
197.3%
49.01
20.12%
Alcon Ag
Alcon Ag
Buy
$38.9B
33.62%
40.22
10.3%

Company Information

infusystem is a growing healthcare company that provides infusion pumps and related products and services for patients in the home, in oncology clinics, at ambulatory surgery centers, and other sites of care from five locations serving all 50 states and canada.

Organization
Infusystem Holdings Inc
Employees
499
CEO
Mr. Richard A. DiIorio
Industry
Health Technology

Discover More

FAQs